Composition

Ceftazidime (as pentahydrate buffered with sodium carbonate) .............................................
0.25, 0.5, 1, or 2 g


Therapeutic Indications

CEFIDIME is indicated for the treatment of the infections listed below in adults and children including neonates (from birth):
Nosocomial pneumonia.

Broncho-pulmonary infections in cystic fibrosis.

Bacterial meningitis.

Chronic suppurative otitis media.

Malignant otitis externa.

Complicated urinary tract infections.

Complicated skin and soft tissue infections.

Complicated intra-abdominal infections.

Bone and joint infections.

Peritonitis associated with dialysis in patients on CAPD.

Treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.

CEFIDIME may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.

CEFIDIME may be used in the peri-operative prophylaxis of urinary tract infections in patients undergoing transurethral resection of the prostate (TURP).

The selection of CEFIDIME should take into account its antibacterial spectrum, which is mainly restricted to aerobic Gram negative bacteria.

CEFIDIME should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity.

Consideration should be given to official guidelines on the appropriate use of antibacterial agents.